RCMU
TECH icon

Rokos Capital Management (UK)’s Bio-Techne TECH Stock Holding History

Rokos Capital Management (UK)’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-75,600
Closed -$5.53M – 83
2022
Q3 		$5.53M Buy
+75,600
New +$6.53M 0.16% 61

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Rokos Capital Management (UK)'s TECH Position: Q4 2022 in Review

Rokos Capital Management (UK) sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 75,600 shares — an estimated $5.53M sold.

Rokos Capital Management (UK) first reported a position in TECH in Q3 2022 and held it in 1 quarter. The position peaked at $5.53M in Q3 2022. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • Rokos Capital Management (UK) reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 75,600 Bio-Techne shares in Q4 2022, an estimated $5.53M.
  • Rokos Capital Management (UK) first reported a position in Bio-Techne in Q3 2022 and held it in 1 quarter.
  • Rokos Capital Management (UK)'s Bio-Techne position peaked at $5.53M in Q3 2022.
  • 545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Rokos Capital Management (UK)'s 13F filing for Q4 2022, filed 14 Feb 2023.